Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation

Transplant Infectious Disease

Volumn 15, Issue 1, 2013, Pages 104-109

  Moon, S M ^a,b   Lee, S O ^a   Choi, S H ^a   Kim, Y S ^a   Woo, J H ^a   Yoon, D H ^a   Suh, C ^a   Kim, D Y ^a   Lee, J H ^a   Lee, Je H ^a   Lee, K H ^a   Kim, S H ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Hematopoietic stem cell transplantation; QuantiFERON TB; Tuberculin skin test; Tuberculosis

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIUM DETECTION; BCG VACCINATION; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNE FUNCTION TEST; INJECTION SITE SCAR; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTIFERON TB GOLD IN TUBE TEST; TREATMENT OUTCOME; TUBERCULIN TEST;

ADULT; BCG VACCINE; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; TUBERCULIN TEST;

EID: 84873473769     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2012.00765.x     Document Type: Article

References (17)

1. Gea-Banacloche J. Risks and epidemiology of infections after allogeneic hematopoietic stem cell transplantation. In: Bowden RA, Ljungman P, Snydman DR, eds. Transplant Infections. (3rd edn.) Philadelphia, PA: Lippincott Williams & Wilkins, 2010: 53-66.
2. Lee DG, Kim SH, Kim SY, et al. Evidence-based guidelines for empirical therapy of neutropenic fever in Korea. Korean J Intern Med 2011; 26 (2): 220-252.
3. Budak-Alpdogan T, Tangün Y, Kalayoglu-Besisik S, et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 2000; 6 (4): 370-374.
4. George B, Mathews V, Srivastava V, Srivastava A, Cahndy M. Tuberculosis among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2001; 27 (9): 973-975.
5. Munoz P, Rodriguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005; 40 (4): 581-587.
6. Kim SH, Lee SO, Park JB, et al. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant 2011; 11 (9): 1927-1235.
7. Park KH, Cho OH, Ko KB, et al. Serial testing of T-SPOT. TB assays with anti-tuberculosis therapy in patients with extrapulmonary tuberculosis. Infect Chemother 2011; 43 (3): 245-250.
8. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33 (1): 159-174.
9. Philips M, Basa-Dalay V, Bothamley G, et al. Breath biomarkers of active tuberculosis. Tuberculosis 2010; 90 (2): 145-151.
10. Manuel O, Humar A, Preiksaitis J, et al. Comparison of Quantiferon-TB Gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007; 7 (12): 2797-2801.
11. Lindemann M, Dioury Y, Beckebaum S, et al. Diagnosis of tuberculosis infection in patients awaiting liver transplantation. Hum Immunol 2009; 70 (1): 24-28.
12. Kim SH, Song KH, Choi SJ, et al. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009; 122 (2): 189-195.
13. Kim SH, Lee SO, Park IA, et al. Diagnostic usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation. Transpl Infect Dis 2010; 12 (2): 113-119.
14. Diel R, Goletti D, Ferrara G, et al. Interferon-gamma releasing assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systemic review and meta-analysis. Eur Respir J 2011; 37 (1): 88-99.
15. Ferrara G, Losi M, Meacci M, et al. Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2005; 172 (5): 631-635.
16. Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009; 33 (4): 812-815.
17. Tanguay S, Killion JJ. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res 1994; 13 (4): 259-263.